Recursion Pharmaceuticals Inc. (RXRX) Social Stream
RECURSION PHARMACEUTICALS INC (RXRX) Price Targets From Analysts
Use the tables below to see what analysts covering RECURSION PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 5 | $37 | $30 | $33.5 | $6.85 | 389.05% |
| 2021-12-07 | 5 | $37 | $30 | $33 | $6.85 | 381.75% |
| 2021-12-08 | 5 | $37 | $31 | $34.2 | $6.85 | 399.27% |
| 2022-01-14 | 5 | $37 | $28 | $32.8 | $6.85 | 378.83% |
| 2022-03-04 | 5 | $37 | $10 | $28.4 | $6.85 | 314.6% |
| 2022-05-10 | 4 | $37 | $10 | $22 | $6.85 | 221.17% |
| 2022-05-12 | 4 | $37 | $10 | $18.25 | $6.85 | 166.42% |
| 2022-05-18 | 5 | $37 | $9 | $18 | $6.85 | 162.77% |
| 2022-08-09 | 5 | $37 | $7 | $15.8 | $6.85 | 130.66% |
| 2022-08-13 | 5 | $37 | $8 | $16 | $6.85 | 133.58% |
| 2022-08-23 | 5 | $37 | $8 | $16.2 | $6.85 | 136.5% |
| 2022-09-10 | 6 | $37 | $8 | $16.2 | $6.85 | 136.5% |
| 2022-09-17 | 6 | $20 | $8 | $12.8 | $6.85 | 86.86% |
| 2022-11-08 | 5 | $20 | $8 | $13 | $6.85 | 89.78% |
| 2022-11-11 | 5 | $20 | $9 | $13.2 | $6.85 | 92.7% |
| 2023-02-08 | 5 | $20 | $8 | $13.2 | $6.85 | 92.7% |
| 2023-03-01 | 5 | $20 | $9 | $13.4 | $6.85 | 95.62% |
| 2023-03-06 | 5 | $20 | $9 | $13.6 | $6.85 | 98.54% |
| 2023-05-03 | 6 | $20 | $9 | $14.166 | $6.85 | 106.8% |
| 2023-05-09 | 6 | $17 | $9 | $12.833 | $6.85 | 87.34% |
| 2023-05-12 | 6 | $17 | $9 | $11.833 | $6.85 | 72.74% |
| 2023-06-06 | 7 | $17 | $8 | $11.285 | $6.85 | 64.74% |
| 2023-07-12 | 7 | $17 | $8 | $11.428 | $6.85 | 66.83% |
| 2023-08-29 | 8 | $33 | $9 | $14.875 | $6.85 | 117.15% |
| 2023-11-10 | 7 | $33 | $9 | $15.428 | $6.85 | 125.23% |
| 2023-11-13 | 7 | $33 | $9 | $15.285 | $6.85 | 123.14% |
The Trend in the Analyst Price Target
RXRX's average price target has moved down $0.52 over the prior 15 months.
Over the past 42 weeks, RXRX's average upside potential has been 87.53%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 5 | 20 | 8 | 13.200 | 8.30 | 59.04% |
| 2023-05-03 | 6 | 20 | 9 | 14.166 | 5.16 | 174.53% |
| 2023-05-08 | 6 | 17 | 9 | 12.833 | 5.60 | 129.16% |
| 2023-08-29 | 7 | 33 | 9 | 15.714 | 8.53 | 84.22% |
| 2023-11-13 | 7 | 33 | 9 | 15.285 | 5.83 | 162.18% |
RXRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.29 | 2 | 1 | 4 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 20 months, RXRX's average broker recommendation rating worsened by 0.29.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, RECURSION PHARMACEUTICALS INC's variance in analysts' estimates is lower than -2388.38% of them.
- RECURSION PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 2476.61% of all US stocks.
- In terms of how RECURSION PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 751.32% of that group.
- RXRX has a higher number of analysts covering the stock than 834.13% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to RECURSION PHARMACEUTICALS INC are EXAI, SNDL, and ACB.
View All Top Stocks by Price Target
Is RXRX a Buy, Hold or Sell? See the POWR Ratings now!